281 related articles for article (PubMed ID: 24430187)
1. Prion disease tempo determined by host-dependent substrate reduction.
Mays CE; Kim C; Haldiman T; van der Merwe J; Lau A; Yang J; Grams J; Di Bari MA; Nonno R; Telling GC; Kong Q; Langeveld J; McKenzie D; Westaway D; Safar JG
J Clin Invest; 2014 Feb; 124(2):847-58. PubMed ID: 24430187
[TBL] [Abstract][Full Text] [Related]
2. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
3. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
4. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
5. Protease-resistant prions selectively decrease Shadoo protein.
Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation.
Westaway D; Genovesi S; Daude N; Brown R; Lau A; Lee I; Mays CE; Coomaraswamy J; Canine B; Pitstick R; Herbst A; Yang J; Ko KW; Schmitt-Ulms G; Dearmond SJ; McKenzie D; Hood L; Carlson GA
PLoS Pathog; 2011 Nov; 7(11):e1002391. PubMed ID: 22114562
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
8. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease and scrapie prions.
Prusiner SB
Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific prion-protein conformation determined by metal ions.
Wadsworth JD; Hill AF; Joiner S; Jackson GS; Clarke AR; Collinge J
Nat Cell Biol; 1999 May; 1(1):55-9. PubMed ID: 10559865
[TBL] [Abstract][Full Text] [Related]
12. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie.
Thorne L; Terry LA
J Gen Virol; 2008 Dec; 89(Pt 12):3177-3184. PubMed ID: 19008409
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of scrapie inactivation is enhanced by copper.
McKenzie D; Bartz J; Mirwald J; Olander D; Marsh R; Aiken J
J Biol Chem; 1998 Oct; 273(40):25545-7. PubMed ID: 9748215
[TBL] [Abstract][Full Text] [Related]
14. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
[TBL] [Abstract][Full Text] [Related]
15. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
16. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
[TBL] [Abstract][Full Text] [Related]
17. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
18. Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
Beringue V; Mallinson G; Kaisar M; Tayebi M; Sattar Z; Jackson G; Anstee D; Collinge J; Hawke S
Brain; 2003 Sep; 126(Pt 9):2065-73. PubMed ID: 12821516
[TBL] [Abstract][Full Text] [Related]
19. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
20. Function of Prion Protein and the Family Member, Shadoo.
Onodera T; Nishimura T; Sugiura K; Sakudo A
Curr Issues Mol Biol; 2020; 36():67-88. PubMed ID: 31559969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]